US 10272132
Peptide and peptidomimetic inhibitors
granted A61KA61K38/00A61K38/10
Quick answer
US patent 10272132 (Peptide and peptidomimetic inhibitors) held by RA PHARMACEUTICALS, INC. expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RA PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/10, A61K45/06, A61K47/60